Modafinil is a moderate medical stimulant that works by promoting wakefulness. It is primarily used for the treatment of narcolepsy, depression, obstructive sleep apnea, and other various sleep disorders. Modafinil is an FDA-approved stimulant for clinical use except for ADHD. It is often used as an Off-Label for people with ADHD to treat symptoms in adults (above 18 years) and older.
Read more to determine about Modafinil for ADHD off-label uses and its effectiveness.
What Is Modafinil (Provigil)?
Modafinil comes with the brand name Provigil. It is a non-amphetamine central nervous stimulant medication. Modafinil is also a eugeroic medical drug that enhances alertness, cognitive functioning, wakefulness, and quality of life. Provigil (Modafinil) is increasingly used off-label for attention deficit hyperactivity disorder (ADHD), sleep disorders, and Bipolar Depression.
Even so, it is not approved for ADHD, but some individuals have shown improvement in their symptoms. Additionally, a large company offering coated modafinil medicine to adults over 18 years with ADHD revealed improvement in ADHD symptoms over placebo.
ADHD Management with Modafinil: Mechanism of Action
Modafinil is a moderate medical stimulant that works by improving various neurotransmitter regulation. It targets the specific brain area to boost neurotransmitter activity and stimulate hypothalamic regions. However, Modafinil is still unknown in terms of a particular mechanism by which it acts. It also regulates the executive chemical functioning of the brain. Modafinil does not bind to the dopamine and norepinephrine receptors but improves attention, wakefulness, and impulse control. By elevating the dopamine in the brain, Modafinil can improve the symptoms of ADHD.
Clinical Studies of Modafinil for ADHD Treatment
The FDA does not allow Modafinil for the clinical treatment of ADHD. However, it is also evident that several studies indicate Modafinil efficacy in Attention Deficit Hyperactivity Disorder (ADHD) treatment. Currently, It is used as an alternative Off-Label medical stimulant for adult ADHD sufferers.
- A small study was conducted with double-bind coated modafinil tablets for 20 adults with ADHD. They were treated with Modafinil 200 mg per day to observe the symptoms. It showed decreased impulsivity and enhanced cognitive functioning in them.
- Another study indicates the safety of Modafinil in children and adults, and it came up with mixed results. Some individuals found nothing, and others got mild headaches, insomnia, and decreased hunger while using Modafinil.
Furthermore, Numerous studies suggest that Modafinil is well-tolerated for use in adults, but it still needs further research to identify the potential of the stimulant.
Modafinil (Provigil) Side Effects:
Modafinil is considered a safe and easily accepted medical stimulant as compared to other abusive stimulants. There are some common modafinil side effects reported after using Modafinil (Provigil), such as:
- Headache
- Nausea
- Acute Insomnia
- Anxiety
- Stomach Aches
- Decreased hunger
Some individuals also face serious modafinil side effects due to its usage in the long term, such as:
- Increased psychiatric risk
- Gastrointestinal Issues
- Heart Disease
- Vertigo
- Depression
Furthermore, These serious modafinil side effects are not common, but they can come with long-term use. It is essential to consult the healthcare professional to determine the usage and specific duration before using Modafinil (Provigil).
Modafinil Dosage: Is Provigil 100mg Effective for ADHD Management?
Modafinil (Provigil) dosage for ADHD depends on several factors such as age, medical condition, and severity of symptoms. It is used as an off-label for ADHD management. Modafinil comes in tablet form with two strengths, including 100mg, 200mg, etc. Several studies found that Provigil 100mg is effective for mild to moderate ADHD symptoms. It also boosts executive and cognitive function and concentration. Typically, the recommended dosage for adult ADHD suffers is 100-200mg/day.
In addition, if Modafinil is taken for an extended period and consumed in excess, it can cause irregular heartbeat, dizziness, Nausea, and hallucinations. It is vital to connect with healthcare professionals to determine the suitable dosage for an individual.
Legal Considerations for Using Modafinil Off-Label for ADHD
Although Modafinil is not an approved medical stimulant for ADHD, it is a low potential abuse controlled substance compared to other drugs. The use of Modafinil for ADHD is considered off-label, which means there is a need for important legal and regulatory considerations. Here’s how:
Prescription Regulations: Patients should have obtained a legal modafinil prescription from a licensed healthcare professional. The misuse of Modafinil without any prescription can lead to serious conditions, including legal penalties.
International Regulations: The use of Modafinil for ADHD management is prohibited in many countries, which can lead to difficulty while purchasing it. Having a proper prescription from a licensed doctor while travelling internationally is crucial.
Furthermore, When consuming Modafinil for ADHD management, it is significant for both healthcare professionals and patients to ensure compliance with local and federal regulations.
Conclusion
Modafinil (Provigil) is often used as an off-label medicine for ADHD management, even if the FDA does not clinically approve it. It is a moderate stimulant which gives less potential abuse compared to other potent stimulants. Several studies show promising results in its efficacy in improving cognitive function, memory, etc. Consult with a licensed healthcare professional to differentiate the correct dosage of Provigil for you.
Reference list
Amiri, S., Mohammadi, M.-R., Mohammadi, M., Nouroozinejad, G.-H., Kahbazi, M. and Akhondzadeh, S. (2008). Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(1), pp.145–149. doi:https://doi.org/10.1016/j.pnpbp.2007.07.025.
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A.J., Carucci, S., Atkinson, L.Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.-C., Shokraneh, F., Xia, J. and Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry, [online] 5(9), pp.727–738. doi:https://doi.org/10.1016/s2215-0366(18)30269-4.
Gerrard, P. and Malcolm, R. (2007). Mechanisms of modafinil: A review of current research. Neuropsychiatric disease and treatment, [online] 3(3), pp.349–64. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654794/.
wang, sheng-min (2017). Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research, [online] 84, pp.292–300. doi:https://doi.org/10.1016/j.jpsychires.2016.09.034.
Wisor, J.P. and Eriksson, K.S. (2005). Dopaminergic—adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience, 132(4), pp.1027–1034. doi:https://doi.org/10.1016/j.neuroscience.2005.02.003.
Greenblatt, K. and Adams, N. (2020). Modafinil. [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK531476/.
